Valar Labs

1 article

Holographic display in a futuristic lab showing AI analysis of bladder cancer risk, representing a medical diagnostic breakthrough.

AI test predicts bladder cancer risk, improves prognosis

The US Food and Drug Administration (FDA) has fast-tracked Valar Labs' Vesta Bladder Risk Stratify Dx, an AI-powered test that analyzes routine pathology slides to predict bladder cancer risk.

Jenna Wallace·May 21, 2026